学术探索
学术期刊
新闻热点
数据分析
智能评审

The drug budget silo mentality in Europe: An overview

被引：39
作者：
Garrison, L
Towse, A
机构：
[1] Roche Pharmaceut, Hlrth Econ & Strateg Pricing, CH-4070 Basel, Switzerland
[2] Off Hlth Econ, London, England
来源：
VALUE IN HEALTH | 2003年 / 6卷
关键词：
D O I：
10.1046/j.1524-4733.6.s1.1.x
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
[No abstract available]
引用
收藏
页码：S1 / S9
页数：9
相关论文
共 7 条
[1]   Challenges to achieving value in drug spending in a decentralized country:: The Spanish case [J].
Antoñanzas, F .
VALUE IN HEALTH, 2003, 6 :S52-S63
[2]   The drug budget silo mentality: The Dutch case [J].
Koopmanschap, MA ;
Rutten, FFH .
VALUE IN HEALTH, 2003, 6 :S46-S51
[3]   The drug budget silo mentality: The French case [J].
Le Pen, C .
VALUE IN HEALTH, 2003, 6 :S10-S19
[4]   Spending on pharmaceuticals in Italy: Macro constraints with local autonomy [J].
Mapelli, V ;
Lucioni, C .
VALUE IN HEALTH, 2003, 6 :S31-S45
[5]   UK budgetary systems and new health-care technologies [J].
McGuire, A ;
Litt, M .
VALUE IN HEALTH, 2003, 6 :S64-S73
[6]  
*OECD, 2002, OECD HLTH DAT 2002 C
[7]   Using disease management and market reforms to address the adverse economic effects of drug budgets and price and reimbursement regulations in Germany [J].
Schwermann, T ;
Greiner, W ;
Von der Schulenburg, JMG .
VALUE IN HEALTH, 2003, 6 :S20-S30
1